Comprehensive Arrhythmia and Cardiomyopathy Panel

Casandra

Casandra Test Code PG93804Version 1 (DRAFT)

Performing Lab

Lab Prevention GeneticsLab Test ID 2663CPT Code 81439

Comprehensive Arrhythmia and Cardiomyopathy Panel

Clinical Use

Use

This test is for individuals with relevant features who have a clinical or suspected diagnosis of cardiac arrhythmia and/or cardiomyopathy. It is also for individuals with unexplained sudden cardiac death/arrest and individuals with a family history suggestive of cardiac arrhythmia and/or cardiomyopathy.

Special Instructions

The test is offered on both Exome and Genome platforms, and can be ordered with additional options like Exome-Wide CNV Analysis or STAT Testing. Orders can be placed online through myPrevent, or by fax using the Test Requisition Form available for download.

Limitations

The tests have not been cleared or approved by the US Food and Drug Administration. The performance characteristics of the tests were validated by PreventionGenetics LLC under CAP and CLIA regulations, but specific limitations or sensitivity parameters are not provided.

Test Details

New York Approved

Methodology

NGS (CGP)

Biomarkers

The panel includes sequencing of 169 genes utilizing Next Generation Sequencing with CNV on the Exome or Genome platform. It is intended to provide a comprehensive genetic analysis for arrhythmia and cardiomyopathy conditions.

NGS with CNV Analysis • CGP